Celldex Therapeutics, Inc. — Director's Dealing 2015

Sep 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2015-09-11

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-11	Common Stock, par value $0.001 per share	M	10000	$4.5	Acquired	35109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-11	Incentive Stock Option	$4.5	M	10000	Disposed	2020-01-21	Common Stock (10000)	Direct

Footnotes

F1: Includes 500 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015.

F2: As of January 21, 2014, the option was fully vested.